Profil
Al Blunt worked as Vice President-Medical at Advaxis, Inc. from 2017 to 2018.
He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from City College.
Anciens postes connus de Al Blunt
| Sociétés | Poste | Fin |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2018 |
Formation de Al Blunt
| University of Pennsylvania | Doctorate Degree |
| City College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
